PREDICTIVE ONCOLOGY INC (POAI) Stock Income Statement
NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.62M | 1.63M | 1.51M | 1.42M | 1.25M | |||
| Cost Of Goods | 826.10K | 609.20K | 510.00K | 490.00K | 450.00K | |||
| Gross Profit | 797.70K | 1.02M | 1.00M | 930.00K | 810.00K | |||
| Operating Expenses | 11.74M | 12.97M | 16.26M | 14.40M | 13.29M | |||
| Selling, General, and Administrative Expenses | 8.72M | 9.62M | 12.47M | 11.71M | 10.94M | |||
| Operating Income | -10.94M | -11.95M | -15.26M | -13.47M | -12.49M | |||
| Interest Income/Expense | 1.40K | 12.50K | 120.00K | 160.00K | 3.06M | |||
| Other Income/Expense | 77.90K | 87.70K | 180.00K | -60.00K | -1.58M | |||
| Non Recurring Items | N/A | -162.90K | -10.77M | -6.96M | -14.87M | |||
| Income Before Taxes | -10.86M | -12.02M | -25.74M | -20.32M | -25.88M | |||
| Income Tax | N/A | N/A | 0.00 | -660.00K | N/A | |||
| Net Income | -12.66M | -13.98M | -25.74M | -19.66M | -26.44M | |||
| EBITDA | -10.78M | -11.71M | -13.95M | -12.13M | -11.47M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.32 | -3.48 | -7.05 | -7.16 | -44.06 | |||
| Non GAAP EPS | N/A | N/A | N/A | -0.37 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 49.13% | 62.57% | 66.23% | 65.49% | 64.80% | |||
| Profit Margin | -779.92% | -859.13% | -1704.64% | -1384.51% | -2115.20% | |||
| Operating Profit Margin | -673.70% | -734.46% | -1010.60% | -948.59% | -999.20% | |||
All data in USD